Equity Details
Price & Market Data
Price: $0.75
Daily Change: +$0.0565 / 7.53%
Daily Range: $0.663 - $0.765
Market Cap: $7,288,934
Daily Volume: 58,671
Performance Metrics
1 Week: -3.18%
1 Month: -11.39%
3 Months: -20.34%
6 Months: -36.36%
1 Year: -40.68%
YTD: -36.36%
About Evogene Ltd. (EVGN)
Comprehensive financial data on Evogene Ltd. (EVGN). Trading at 0.75, it has a daily change of +$0.0565 / 7.53%. Market cap: 7,288,934. Review its performance from the last week to the last year.
Company Details
Employees: 52
Sector: Health technology
Industry: Biotechnology
Country: Israel
Details
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
